期刊文献+

依折麦布联合辛伐他汀对糖尿病合并高胆固醇血症患者的疗效观察 被引量:1

原文传递
导出
摘要 目的评价依折麦布对糖尿病合并高胆固醇血症患者的疗效和安全性。方法 58例临床确诊为糖尿病合并高胆固醇血症患者按随机的原则分为治疗组(依折麦布联合辛伐他汀)与对照组(常用辛伐他汀),治疗疗程均为12周,观察两组治疗前后空腹血糖、餐后2h血糖、总胆固醇、低密度脂蛋白胆固醇(LDL-C)、高敏C-反应蛋白(hs-CRP)、血肌酐(Scr)、肌酸激酶、谷丙转氨酶、谷草转氨酶。结果两组LDL-C治疗后均下降(P<0.05),且治疗组较对照组明显(P<0.01);治疗组空腹血糖、餐后2h血糖较对照组有改善(P<0.05);两组酶学及肌酐变化未见明显差异。结论依折麦布能有效改善糖尿病患者的血脂谱、改善空腹血糖及餐后2h血糖水平,降低(hs-CRP),且安全性良好。
出处 《中国药物经济学》 2014年第5期45-46,共2页 China Journal of Pharmaceutical Economics
  • 相关文献

参考文献4

  • 1何培源,李静,蒋立新.依折麦布临床研究最新进展[J].心血管病学进展,2012,33(2):168-171. 被引量:33
  • 2Stein E,Stender S,Mata P, et al.Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia:eficiency and safety of ezetimibe co-administered with atorvastatin[J].Am J Cardiol,2005,96:556-563.
  • 3Ballantyne CM,Weiss R,Moceetti T, et al .Eficiency and safety of rosuvastatin 40 mg alone and in combination with ezetimibe in patients at high risk of cardiovascular disease(results from the EXPLORER Study)[J].Am J Cardiol,2007,99:673-680.
  • 4Baigent C,Keech A,Kearney PM,et al.Efficiency and safety of cholesterol-lowering treatment:prospective meta-analysis of data from 90056 participants in 14 randomised trials of statins[J].Lancet, 2005,366:1267-1278.

二级参考文献32

  • 1Durrington P.Dyslipidaemia[J].Lancet,2003,362:717-731.
  • 2LaRosa JC.Understanding risk in hypercholesterolemia[J].Clin Cardiol,2003,26(suppl1):13-16.
  • 3LaRosa JC,He J,Vupputuri S.Effect of statins on risk of coronary disease:a meta-analysis of randomized controlled trials[J].JAMA,1999,282:2340-2346.
  • 4Law MR,Wald NJ,Rudnicka AR.Quantifying effect of statins on low density lipoprotein cholesterol,ischaemic heart disease,and stroke:systematic review and meta-analysis[J].BMJ,2003,326:1423-1426.
  • 5Cholesterol Treatment Trialists(CTT)Collaborators.Efficacy and safety of cho-lesterol-lowering treatment:prospective meta-analysis of data from90056partic-ipants in14randomised trials of statins[J].Lancet,2005,366:1267-1278.
  • 6Mikhailidis DP,Wierzbicki AS,Daskalopoulou SS,et al.The use of ezetimibe in achieving low density lipoprotein lowering goals in clinical practice:position statement of a United Kingdom consensus panel[J].Curr Med Res Opin,2005,2:959-969.
  • 7Sudhop T,Lutjohann D,Kodal A,et al.Inhibition of intestinal cholesterol ab-sorption by ezetimibe in humans[J].Circulation.2002,106:1943-1948.
  • 8Kosoglou T,Meyer I,Veltri EP,et al.Pharmacodynamic interaction between the new selective cholesterol absorption inhibitor ezetimibe and simvastatin[J].Br J Clin Pharmacol,2002,54:309-319.
  • 9Patrick JE,Kosoglou T,Stauber KL,et al.Disposition of the selective choles-terol absorption inhibitor ezetimibe in healthy male subjects[J].Drug Metab Dispos,2002,30:430-437.
  • 10Pandor A,Ara RM,Tumur I,et al.Ezetimibe monotherapy for cholesterol lowering in2,722people:systematic review and meta-analysis of randomized controlled trials[J].J Intern Med,2009,265:568-580.

共引文献32

同被引文献14

引证文献1

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部